BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25886513)

  • 1. Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey.
    Akinyemiju TF; McDonald JA; Lantz PM
    BMC Public Health; 2015 Apr; 15():382. PubMed ID: 25886513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and Cervical Cancer Screening Prevalence and Associated Factors among Women in the South African General Population.
    Phaswana-Mafuya N; Peltzer K
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1465-1470. PubMed ID: 29936716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in receipt of breast and cervical cancer screening for rural women age 18 to 64 with disabilities.
    Horner-Johnson W; Dobbertin K; Iezzoni LI
    Womens Health Issues; 2015; 25(3):246-53. PubMed ID: 25864023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to increase uptake of cervical screening in sub-Saharan Africa: a scoping review using the integrated behavioral model.
    Lott BE; Trejo MJ; Baum C; McClelland DJ; Adsul P; Madhivanan P; Carvajal S; Ernst K; Ehiri J
    BMC Public Health; 2020 May; 20(1):654. PubMed ID: 32393218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social disparities in access to breast and cervical cancer screening by women living in Spain.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
    Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's Cancer Care in Iran.
    Joulaei H; Zarei N
    Cancer Control; 2019; 26(1):1073274819848432. PubMed ID: 31094222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
    Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
    BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
    AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review.
    Lim JN; Ojo AA
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26853214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and cervical cancer screening and associated factors among older adult women in South Africa.
    Peltzer K; Phaswana-Mafuya N
    Asian Pac J Cancer Prev; 2014; 15(6):2473-6. PubMed ID: 24761849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rural physicians' perspectives on cervical and breast cancer screening: a gender-based analysis.
    Ahmad F; Stewart DE; Cameron JI; Hyman I
    J Womens Health Gend Based Med; 2001 Mar; 10(2):201-8. PubMed ID: 11268303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
    Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
    Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.